Premier Anti-Aging Co., Ltd.
4934.T · JPX
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.12 | -0.05 | 0.08 | -0.25 |
| FCF Yield | 19.16% | -5.23% | 17.62% | -20.15% |
| EV / EBITDA | 4.34 | -8.35 | -16.01 | 5.96 |
| Quality | ||||
| ROIC | 6.36% | 1.61% | -6.15% | 13.65% |
| Gross Margin | 76.65% | 79.09% | 72.89% | 78.52% |
| Cash Conversion Ratio | 3.13 | -0.47 | -3.67 | -1.29 |
| Growth | ||||
| Revenue 3-Year CAGR | -15.09% | -15.64% | -6.99% | 32,368,013.41% |
| Free Cash Flow Growth | 465.06% | -124.02% | 146.64% | -231.64% |
| Safety | ||||
| Net Debt / EBITDA | -3.87 | 3.70 | 5.57 | -0.58 |
| Interest Coverage | 32.47 | 6.32 | -32.55 | 162.26 |
| Efficiency | ||||
| Inventory Turnover | 2.59 | 2.68 | 3.75 | 1.67 |
| Cash Conversion Cycle | 153.57 | 149.43 | 112.96 | 229.79 |